Rank | Gene Set | Z-score |
---|---|---|
1 | uronic acid metabolic process (GO:0006063) | 6.82550110 |
2 | glucuronate metabolic process (GO:0019585) | 6.82550110 |
3 | cellular glucuronidation (GO:0052695) | 6.71872276 |
4 | negative regulation of fatty acid transport (GO:2000192) | 6.39295967 |
5 | regulation of chemokine secretion (GO:0090196) | 5.03728047 |
6 | nucleotide transmembrane transport (GO:1901679) | 4.97214387 |
7 | inner ear receptor cell differentiation (GO:0060113) | 4.86917582 |
8 | regulation of protein activation cascade (GO:2000257) | 4.83678711 |
9 | limb bud formation (GO:0060174) | 4.79734914 |
10 | negative regulation of protein activation cascade (GO:2000258) | 4.75907893 |
11 | regulation of complement activation (GO:0030449) | 4.67296833 |
12 | negative regulation of fibrinolysis (GO:0051918) | 4.63216547 |
13 | intestinal cholesterol absorption (GO:0030299) | 4.54081978 |
14 | phenylpropanoid metabolic process (GO:0009698) | 4.35242491 |
15 | positive regulation of chemokine secretion (GO:0090197) | 4.29510789 |
16 | urea metabolic process (GO:0019627) | 4.29016937 |
17 | xenobiotic catabolic process (GO:0042178) | 4.28847527 |
18 | myoblast migration (GO:0051451) | 4.26361756 |
19 | negative regulation of complement activation (GO:0045916) | 4.25404969 |
20 | regulation of fibrinolysis (GO:0051917) | 4.22465050 |
21 | urea cycle (GO:0000050) | 4.18452725 |
22 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.13404351 |
23 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.10995439 |
24 | regulation of phospholipase A2 activity (GO:0032429) | 4.10586868 |
25 | energy homeostasis (GO:0097009) | 4.09740650 |
26 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.08359017 |
27 | replicative senescence (GO:0090399) | 4.06276595 |
28 | ER overload response (GO:0006983) | 3.99582913 |
29 | cell differentiation involved in metanephros development (GO:0072202) | 3.96254025 |
30 | nitrogen cycle metabolic process (GO:0071941) | 3.88876794 |
31 | L-phenylalanine metabolic process (GO:0006558) | 3.82814629 |
32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.82814629 |
33 | cell aggregation (GO:0098743) | 3.80949081 |
34 | cartilage condensation (GO:0001502) | 3.80949081 |
35 | L-phenylalanine catabolic process (GO:0006559) | 3.72529036 |
36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.72529036 |
37 | protein carboxylation (GO:0018214) | 3.68531086 |
38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.68531086 |
39 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.68092413 |
40 | midgut development (GO:0007494) | 3.63978676 |
41 | regulation of metalloenzyme activity (GO:0048552) | 3.61849804 |
42 | positive regulation of actin filament depolymerization (GO:0030836) | 3.58033848 |
43 | Golgi transport vesicle coating (GO:0048200) | 3.50521654 |
44 | COPI coating of Golgi vesicle (GO:0048205) | 3.50521654 |
45 | mechanoreceptor differentiation (GO:0042490) | 3.50460080 |
46 | glomerulus development (GO:0032835) | 3.48177181 |
47 | daunorubicin metabolic process (GO:0044597) | 3.42711957 |
48 | polyketide metabolic process (GO:0030638) | 3.42711957 |
49 | doxorubicin metabolic process (GO:0044598) | 3.42711957 |
50 | notochord development (GO:0030903) | 3.38682331 |
51 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.36054835 |
52 | signal peptide processing (GO:0006465) | 3.32145844 |
53 | prostaglandin biosynthetic process (GO:0001516) | 3.29054623 |
54 | prostanoid biosynthetic process (GO:0046457) | 3.29054623 |
55 | homocysteine metabolic process (GO:0050667) | 3.21023574 |
56 | COPII vesicle coating (GO:0048208) | 3.19148797 |
57 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.18986233 |
58 | plasma lipoprotein particle assembly (GO:0034377) | 3.18130007 |
59 | myelin assembly (GO:0032288) | 3.16963913 |
60 | cholesterol biosynthetic process (GO:0006695) | 3.16453761 |
61 | hepatocyte differentiation (GO:0070365) | 3.16101898 |
62 | response to nitrosative stress (GO:0051409) | 3.14976685 |
63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.14456794 |
64 | DNA double-strand break processing (GO:0000729) | 3.12491104 |
65 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.09492274 |
66 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.09492274 |
67 | purine ribonucleotide transport (GO:0015868) | 3.09225548 |
68 | cellular response to gamma radiation (GO:0071480) | 3.08772517 |
69 | glutamate metabolic process (GO:0006536) | 3.08296171 |
70 | one-carbon compound transport (GO:0019755) | 3.07703774 |
71 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.06466501 |
72 | regulation of skeletal muscle contraction (GO:0014819) | 3.05981460 |
73 | blood coagulation, intrinsic pathway (GO:0007597) | 3.05911368 |
74 | complement activation, alternative pathway (GO:0006957) | 3.04346626 |
75 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 3.04043285 |
76 | response to follicle-stimulating hormone (GO:0032354) | 3.01533700 |
77 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.98521268 |
78 | iron ion import (GO:0097286) | 2.98371579 |
79 | muscle cell migration (GO:0014812) | 2.96349389 |
80 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.94907035 |
81 | Notch signaling involved in heart development (GO:0061314) | 2.90639835 |
82 | regulation of cholesterol homeostasis (GO:2000188) | 2.89034095 |
83 | nucleobase catabolic process (GO:0046113) | 2.87297266 |
84 | negative regulation of lipase activity (GO:0060192) | 2.86384784 |
85 | cholesterol efflux (GO:0033344) | 2.86089023 |
86 | cysteine metabolic process (GO:0006534) | 2.85411581 |
87 | neural crest cell development (GO:0014032) | 2.85315237 |
88 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.84175355 |
89 | gluconeogenesis (GO:0006094) | 2.83125396 |
90 | polyol transport (GO:0015791) | 2.81630293 |
91 | negative regulation of myoblast differentiation (GO:0045662) | 2.81476087 |
92 | protein-lipid complex assembly (GO:0065005) | 2.79702432 |
93 | nucleotide transport (GO:0006862) | 2.79045698 |
94 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.78776396 |
95 | chondrocyte development (GO:0002063) | 2.78774101 |
96 | sterol biosynthetic process (GO:0016126) | 2.78771222 |
97 | positive regulation of icosanoid secretion (GO:0032305) | 2.78427089 |
98 | negative regulation of humoral immune response (GO:0002921) | 2.77994461 |
99 | fibrinolysis (GO:0042730) | 2.76655926 |
100 | negative regulation of chemokine production (GO:0032682) | 2.74048556 |
101 | bone remodeling (GO:0046849) | 2.72129542 |
102 | myelin maintenance (GO:0043217) | 2.71296357 |
103 | cellular response to BMP stimulus (GO:0071773) | 2.71080405 |
104 | response to BMP (GO:0071772) | 2.71080405 |
105 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.70690348 |
106 | intestinal absorption (GO:0050892) | 2.70317271 |
107 | endothelial cell morphogenesis (GO:0001886) | 2.70113089 |
108 | hexose biosynthetic process (GO:0019319) | 2.68964930 |
109 | endocardial cushion morphogenesis (GO:0003203) | 2.68568426 |
110 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.68140872 |
111 | prostanoid metabolic process (GO:0006692) | 2.67441842 |
112 | prostaglandin metabolic process (GO:0006693) | 2.67441842 |
113 | regulation of plasminogen activation (GO:0010755) | 2.67223337 |
114 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.67170640 |
115 | central nervous system myelination (GO:0022010) | 2.65645662 |
116 | axon ensheathment in central nervous system (GO:0032291) | 2.65645662 |
117 | amyloid precursor protein catabolic process (GO:0042987) | 2.63912717 |
118 | plasma lipoprotein particle remodeling (GO:0034369) | 2.63414551 |
119 | protein-lipid complex remodeling (GO:0034368) | 2.63414551 |
120 | macromolecular complex remodeling (GO:0034367) | 2.63414551 |
121 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.61287688 |
122 | cell adhesion mediated by integrin (GO:0033627) | 2.61194984 |
123 | layer formation in cerebral cortex (GO:0021819) | 2.60662276 |
124 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.59541599 |
125 | glycogen catabolic process (GO:0005980) | 2.58642214 |
126 | sphingomyelin metabolic process (GO:0006684) | 2.58476249 |
127 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.57791221 |
128 | endoplasmic reticulum organization (GO:0007029) | 2.57612794 |
129 | fatty acid elongation (GO:0030497) | 2.57089774 |
130 | heart valve morphogenesis (GO:0003179) | 2.56766577 |
131 | protein K11-linked deubiquitination (GO:0035871) | 2.56536109 |
132 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.56262951 |
133 | negative regulation of mast cell activation (GO:0033004) | 2.55911857 |
134 | regulation of bile acid biosynthetic process (GO:0070857) | 2.55005959 |
135 | female gonad development (GO:0008585) | 2.54973042 |
136 | tyrosine metabolic process (GO:0006570) | 2.53110258 |
137 | viral protein processing (GO:0019082) | 2.51506401 |
138 | L-ascorbic acid metabolic process (GO:0019852) | 2.51381521 |
139 | glutamine family amino acid catabolic process (GO:0009065) | 2.51366221 |
140 | serine family amino acid biosynthetic process (GO:0009070) | 2.50882439 |
141 | cranial suture morphogenesis (GO:0060363) | 2.50832329 |
142 | smooth muscle tissue development (GO:0048745) | 2.50828174 |
143 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.50557073 |
144 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.50556306 |
145 | positive regulation of mitochondrial fission (GO:0090141) | 2.48430721 |
146 | glycerophospholipid catabolic process (GO:0046475) | 2.48086253 |
147 | negative regulation of JUN kinase activity (GO:0043508) | 2.47796223 |
148 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.47689285 |
149 | ganglion development (GO:0061548) | 2.47495431 |
150 | L-serine metabolic process (GO:0006563) | 2.46399533 |
151 | regulation of icosanoid secretion (GO:0032303) | 2.45715639 |
152 | high-density lipoprotein particle remodeling (GO:0034375) | 2.45518560 |
153 | citrulline metabolic process (GO:0000052) | 2.45485535 |
154 | magnesium ion transport (GO:0015693) | 2.44975139 |
155 | polarized epithelial cell differentiation (GO:0030859) | 2.44885438 |
156 | 4-hydroxyproline metabolic process (GO:0019471) | 2.44700743 |
157 | exogenous drug catabolic process (GO:0042738) | 2.44142087 |
158 | eye photoreceptor cell differentiation (GO:0001754) | 2.43775148 |
159 | photoreceptor cell differentiation (GO:0046530) | 2.43775148 |
160 | glyoxylate metabolic process (GO:0046487) | 2.43770958 |
161 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.43761647 |
162 | negative regulation of cholesterol transport (GO:0032375) | 2.43508010 |
163 | negative regulation of sterol transport (GO:0032372) | 2.43508010 |
164 | positive regulation of pseudopodium assembly (GO:0031274) | 2.42958403 |
165 | plasma lipoprotein particle organization (GO:0071827) | 2.41916047 |
166 | negative regulation of cytokine secretion (GO:0050710) | 2.41570405 |
167 | cyclooxygenase pathway (GO:0019371) | 2.41063793 |
168 | microtubule polymerization or depolymerization (GO:0031109) | 2.40581010 |
169 | citrulline biosynthetic process (GO:0019240) | 2.40492774 |
170 | protein retention in ER lumen (GO:0006621) | 2.39291226 |
171 | otic vesicle formation (GO:0030916) | 2.39200521 |
172 | low-density lipoprotein particle remodeling (GO:0034374) | 2.35765490 |
173 | establishment of mitochondrion localization (GO:0051654) | 2.34259903 |
174 | serine family amino acid metabolic process (GO:0009069) | 2.34006721 |
175 | alpha-linolenic acid metabolic process (GO:0036109) | 2.32782071 |
176 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.32687576 |
177 | nuclear pore complex assembly (GO:0051292) | 2.32091031 |
178 | glycolytic process (GO:0006096) | 2.31790884 |
179 | glucan catabolic process (GO:0009251) | 2.31734994 |
180 | monosaccharide biosynthetic process (GO:0046364) | 2.31728318 |
181 | vesicle coating (GO:0006901) | 2.31091089 |
182 | reverse cholesterol transport (GO:0043691) | 2.30946808 |
183 | response to muscle activity (GO:0014850) | 2.29716992 |
184 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.27487488 |
185 | protein hydroxylation (GO:0018126) | 2.27226632 |
186 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.25824232 |
187 | protein-lipid complex subunit organization (GO:0071825) | 2.25574579 |
188 | response to mercury ion (GO:0046689) | 2.24656163 |
189 | glutamine metabolic process (GO:0006541) | 2.24517929 |
190 | plasma lipoprotein particle clearance (GO:0034381) | 2.24235561 |
191 | bile acid metabolic process (GO:0008206) | 2.23212560 |
192 | serine family amino acid catabolic process (GO:0009071) | 2.22458970 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.71761701 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.11863552 |
3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.44022294 |
4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.17835954 |
5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.93108200 |
6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.87788861 |
7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.87207554 |
8 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.84478459 |
9 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.71563636 |
10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.66957991 |
11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.60426893 |
12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.51099987 |
13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.49866930 |
14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.40823259 |
15 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.33141357 |
16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32715579 |
17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30007970 |
18 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.28683084 |
19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24664692 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.22700387 |
21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13328687 |
22 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.13081993 |
23 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.12535191 |
24 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.01547152 |
25 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.01398967 |
26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01123900 |
27 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.97344399 |
28 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.97344399 |
29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.96866191 |
30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96414949 |
31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.86061041 |
32 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84284663 |
33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82762767 |
34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82443299 |
35 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.80278799 |
36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.79174844 |
37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.77693737 |
38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.77078584 |
39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76912053 |
40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.74515841 |
41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.72197489 |
42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.71805316 |
43 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71634797 |
44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69121409 |
45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.69020534 |
46 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.68718273 |
47 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67013671 |
48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66846004 |
49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65376033 |
50 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.60337698 |
51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.59277412 |
52 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.58583788 |
53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.58326688 |
54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.57396795 |
55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57246206 |
56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56736219 |
57 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.56179762 |
58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54815515 |
59 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.54653386 |
60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54404128 |
61 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.54177177 |
62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53263844 |
63 | EWS_26573619_Chip-Seq_HEK293_Human | 1.52451402 |
64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52191592 |
65 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51765711 |
66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51016952 |
67 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.49917331 |
68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.49825591 |
69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49515705 |
70 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.49162690 |
71 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.48720336 |
72 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47989788 |
73 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.47754574 |
74 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47482146 |
75 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.47369994 |
76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.46767615 |
77 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.46633372 |
78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45353681 |
79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44651541 |
80 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44291770 |
81 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.44011099 |
82 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.43386737 |
83 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42109071 |
84 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.41328153 |
85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.39813075 |
86 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39398351 |
87 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39245934 |
88 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.37941350 |
89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37875465 |
90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37720626 |
91 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.35763515 |
92 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35701023 |
93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.34959860 |
94 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.34515759 |
95 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.34150622 |
96 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.34094946 |
97 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33120613 |
98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32848834 |
99 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.31320569 |
100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30691803 |
101 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.30038357 |
102 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.28416181 |
103 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.27877302 |
104 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27412045 |
105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27411993 |
106 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27237223 |
107 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27075454 |
108 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.25887955 |
109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25707387 |
110 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.25418298 |
111 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.25100374 |
112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24661713 |
113 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.22705584 |
114 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22611910 |
115 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22611910 |
116 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22485816 |
117 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21722766 |
118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20981909 |
119 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.18696679 |
120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18639977 |
121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18448435 |
122 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18099357 |
123 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18097288 |
124 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17955576 |
125 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.17531783 |
126 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16227117 |
127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16121659 |
128 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.15958130 |
129 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.15947528 |
130 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14823040 |
131 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 1.14477428 |
132 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.14012665 |
133 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13733778 |
134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12871212 |
135 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.12169300 |
136 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.11924152 |
137 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11652297 |
138 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09825260 |
139 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.09111483 |
140 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08978149 |
141 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08895372 |
142 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07927192 |
143 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.07075459 |
144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06727298 |
145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.06345204 |
146 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.06216628 |
147 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04469517 |
148 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04405095 |
149 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03249581 |
150 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01911879 |
151 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01899471 |
152 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00298800 |
153 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00144880 |
154 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.99235788 |
155 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97718704 |
156 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93682475 |
157 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91342978 |
158 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.91231447 |
159 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91131300 |
160 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89160757 |
161 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.88060344 |
162 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87099957 |
163 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86654384 |
164 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83823287 |
165 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.83402733 |
166 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82750947 |
167 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81474812 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008789_abnormal_olfactory_epithelium | 4.65218313 |
2 | MP0005499_abnormal_olfactory_system | 4.31734706 |
3 | MP0005394_taste/olfaction_phenotype | 4.31734706 |
4 | MP0010030_abnormal_orbit_morphology | 3.35242148 |
5 | MP0003122_maternal_imprinting | 3.24541901 |
6 | MP0002877_abnormal_melanocyte_morpholog | 2.99325178 |
7 | MP0001984_abnormal_olfaction | 2.96448805 |
8 | MP0005365_abnormal_bile_salt | 2.71244501 |
9 | MP0009250_abnormal_appendicular_skeleto | 2.70286870 |
10 | MP0004134_abnormal_chest_morphology | 2.53450379 |
11 | MP0002009_preneoplasia | 2.42438471 |
12 | MP0005503_abnormal_tendon_morphology | 2.37953656 |
13 | MP0000013_abnormal_adipose_tissue | 2.35233270 |
14 | MP0000566_synostosis | 2.29246714 |
15 | MP0005408_hypopigmentation | 2.23039837 |
16 | MP0002233_abnormal_nose_morphology | 2.15412770 |
17 | MP0009697_abnormal_copulation | 2.14516620 |
18 | MP0003950_abnormal_plasma_membrane | 2.13442839 |
19 | MP0003868_abnormal_feces_composition | 2.08817444 |
20 | MP0010234_abnormal_vibrissa_follicle | 2.04241085 |
21 | MP0004233_abnormal_muscle_weight | 2.04058560 |
22 | MP0003186_abnormal_redox_activity | 2.02531250 |
23 | MP0004782_abnormal_surfactant_physiolog | 2.01847124 |
24 | MP0009053_abnormal_anal_canal | 1.99767180 |
25 | MP0001177_atelectasis | 1.99490868 |
26 | MP0003937_abnormal_limbs/digits/tail_de | 1.91463220 |
27 | MP0005360_urolithiasis | 1.90431232 |
28 | MP0001346_abnormal_lacrimal_gland | 1.90331131 |
29 | MP0000762_abnormal_tongue_morphology | 1.88371154 |
30 | MP0005171_absent_coat_pigmentation | 1.84817036 |
31 | MP0002282_abnormal_trachea_morphology | 1.84579914 |
32 | MP0001919_abnormal_reproductive_system | 1.83874747 |
33 | MP0005187_abnormal_penis_morphology | 1.81162404 |
34 | MP0005083_abnormal_biliary_tract | 1.79264454 |
35 | MP0001666_abnormal_nutrient_absorption | 1.78170860 |
36 | MP0003755_abnormal_palate_morphology | 1.75547784 |
37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.74548526 |
38 | MP0005248_abnormal_Harderian_gland | 1.73964201 |
39 | MP0000003_abnormal_adipose_tissue | 1.72030935 |
40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.71876315 |
41 | MP0005647_abnormal_sex_gland | 1.69976319 |
42 | MP0005508_abnormal_skeleton_morphology | 1.68182776 |
43 | MP0002160_abnormal_reproductive_system | 1.67666756 |
44 | MP0002933_joint_inflammation | 1.64814898 |
45 | MP0003252_abnormal_bile_duct | 1.63256917 |
46 | MP0000163_abnormal_cartilage_morphology | 1.62057821 |
47 | MP0002132_abnormal_respiratory_system | 1.61033109 |
48 | MP0005389_reproductive_system_phenotype | 1.59870220 |
49 | MP0005451_abnormal_body_composition | 1.58192649 |
50 | MP0010329_abnormal_lipoprotein_level | 1.57451129 |
51 | MP0001529_abnormal_vocalization | 1.56732272 |
52 | MP0000049_abnormal_middle_ear | 1.56086826 |
53 | MP0002277_abnormal_respiratory_mucosa | 1.56085378 |
54 | MP0000751_myopathy | 1.55650912 |
55 | MP0008438_abnormal_cutaneous_collagen | 1.51439761 |
56 | MP0005646_abnormal_pituitary_gland | 1.50254106 |
57 | MP0003656_abnormal_erythrocyte_physiolo | 1.48242295 |
58 | MP0000372_irregular_coat_pigmentation | 1.45874829 |
59 | MP0005623_abnormal_meninges_morphology | 1.45654285 |
60 | MP0002133_abnormal_respiratory_system | 1.44628317 |
61 | MP0005388_respiratory_system_phenotype | 1.44628317 |
62 | MP0000613_abnormal_salivary_gland | 1.42914129 |
63 | MP0003806_abnormal_nucleotide_metabolis | 1.38046433 |
64 | MP0004270_analgesia | 1.36170929 |
65 | MP0003890_abnormal_embryonic-extraembry | 1.36082722 |
66 | MP0002697_abnormal_eye_size | 1.34154913 |
67 | MP0008057_abnormal_DNA_replication | 1.30912873 |
68 | MP0005076_abnormal_cell_differentiation | 1.29512351 |
69 | MP0002249_abnormal_larynx_morphology | 1.28741645 |
70 | MP0003315_abnormal_perineum_morphology | 1.26763327 |
71 | MP0002269_muscular_atrophy | 1.24321080 |
72 | MP0005332_abnormal_amino_acid | 1.21780278 |
73 | MP0003195_calcinosis | 1.21532264 |
74 | MP0006292_abnormal_olfactory_placode | 1.21433956 |
75 | MP0002876_abnormal_thyroid_physiology | 1.20196837 |
76 | MP0001851_eye_inflammation | 1.19982977 |
77 | MP0001958_emphysema | 1.17917236 |
78 | MP0002115_abnormal_skeleton_extremities | 1.17245161 |
79 | MP0001542_abnormal_bone_strength | 1.16516511 |
80 | MP0005377_hearing/vestibular/ear_phenot | 1.15001000 |
81 | MP0003878_abnormal_ear_physiology | 1.15001000 |
82 | MP0004197_abnormal_fetal_growth/weight/ | 1.14091913 |
83 | MP0003718_maternal_effect | 1.12983151 |
84 | MP0005390_skeleton_phenotype | 1.12839487 |
85 | MP0003279_aneurysm | 1.12096523 |
86 | MP0003943_abnormal_hepatobiliary_system | 1.11052135 |
87 | MP0001188_hyperpigmentation | 1.10586959 |
88 | MP0003941_abnormal_skin_development | 1.10125531 |
89 | MP0003121_genomic_imprinting | 1.09292883 |
90 | MP0002909_abnormal_adrenal_gland | 1.09281291 |
91 | MP0001299_abnormal_eye_distance/ | 1.08317137 |
92 | MP0001915_intracranial_hemorrhage | 1.06571139 |
93 | MP0003136_yellow_coat_color | 1.04952952 |
94 | MP0002971_abnormal_brown_adipose | 1.04176010 |
95 | MP0002113_abnormal_skeleton_development | 1.03097752 |
96 | MP0000733_abnormal_muscle_development | 1.02340322 |
97 | MP0008007_abnormal_cellular_replicative | 1.02339550 |
98 | MP0002234_abnormal_pharynx_morphology | 1.02130799 |
99 | MP0005367_renal/urinary_system_phenotyp | 1.01799030 |
100 | MP0000516_abnormal_urinary_system | 1.01799030 |
101 | MP0004272_abnormal_basement_membrane | 1.01103591 |
102 | MP0002098_abnormal_vibrissa_morphology | 1.00889709 |
103 | MP0001286_abnormal_eye_development | 1.00782705 |
104 | MP0010352_gastrointestinal_tract_polyps | 0.99362318 |
105 | MP0004087_abnormal_muscle_fiber | 0.98766327 |
106 | MP0003786_premature_aging | 0.97221046 |
107 | MP0009780_abnormal_chondrocyte_physiolo | 0.96464002 |
108 | MP0000579_abnormal_nail_morphology | 0.96133636 |
109 | MP0003115_abnormal_respiratory_system | 0.95755090 |
110 | MP0003942_abnormal_urinary_system | 0.95721283 |
111 | MP0005085_abnormal_gallbladder_physiolo | 0.95604366 |
112 | MP0002092_abnormal_eye_morphology | 0.93397858 |
113 | MP0006054_spinal_hemorrhage | 0.93232648 |
114 | MP0002109_abnormal_limb_morphology | 0.93027799 |
115 | MP0000537_abnormal_urethra_morphology | 0.92513088 |
116 | MP0010368_abnormal_lymphatic_system | 0.91145147 |
117 | MP0002060_abnormal_skin_morphology | 0.90991963 |
118 | MP0001661_extended_life_span | 0.90504532 |
119 | MP0002332_abnormal_exercise_endurance | 0.90265741 |
120 | MP0000609_abnormal_liver_physiology | 0.89910954 |
121 | MP0002106_abnormal_muscle_physiology | 0.89820675 |
122 | MP0005409_darkened_coat_color | 0.89690642 |
123 | MP0002163_abnormal_gland_morphology | 0.88999996 |
124 | MP0002116_abnormal_craniofacial_bone | 0.87758116 |
125 | MP0000778_abnormal_nervous_system | 0.87231088 |
126 | MP0000750_abnormal_muscle_regeneration | 0.86917839 |
127 | MP0000747_muscle_weakness | 0.86441330 |
128 | MP0005257_abnormal_intraocular_pressure | 0.86305216 |
129 | MP0005501_abnormal_skin_physiology | 0.85759871 |
130 | MP0009840_abnormal_foam_cell | 0.85044439 |
131 | MP0005164_abnormal_response_to | 0.84251998 |
132 | MP0002118_abnormal_lipid_homeostasis | 0.83642707 |
133 | MP0002139_abnormal_hepatobiliary_system | 0.83250383 |
134 | MP0003385_abnormal_body_wall | 0.80225807 |
135 | MP0000759_abnormal_skeletal_muscle | 0.80153609 |
136 | MP0001879_abnormal_lymphatic_vessel | 0.80030956 |
137 | MP0002177_abnormal_outer_ear | 0.79871541 |
138 | MP0001270_distended_abdomen | 0.78390780 |
139 | MP0008961_abnormal_basal_metabolism | 0.76885647 |
140 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76518985 |
141 | MP0005197_abnormal_uvea_morphology | 0.75880896 |
142 | MP0003123_paternal_imprinting | 0.75437773 |
143 | MP0000639_abnormal_adrenal_gland | 0.75070616 |
144 | MP0008932_abnormal_embryonic_tissue | 0.74924520 |
145 | MP0000678_abnormal_parathyroid_gland | 0.74820479 |
146 | MP0002295_abnormal_pulmonary_circulatio | 0.74772108 |
147 | MP0005275_abnormal_skin_tensile | 0.74300112 |
148 | MP0001119_abnormal_female_reproductive | 0.74115639 |
149 | MP0005084_abnormal_gallbladder_morpholo | 0.73435360 |
150 | MP0009672_abnormal_birth_weight | 0.72051628 |
151 | MP0000383_abnormal_hair_follicle | 0.70831356 |
152 | MP0003724_increased_susceptibility_to | 0.70580146 |
153 | MP0002111_abnormal_tail_morphology | 0.70475913 |
154 | MP0002938_white_spotting | 0.69993797 |
155 | MP0001963_abnormal_hearing_physiology | 0.69883261 |
156 | MP0010678_abnormal_skin_adnexa | 0.69649467 |
157 | MP0004484_altered_response_of | 0.69358337 |
158 | MP0005423_abnormal_somatic_nervous | 0.68741524 |
159 | MP0002090_abnormal_vision | 0.68540680 |
160 | MP0005375_adipose_tissue_phenotype | 0.68539862 |
161 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68303513 |
162 | MP0002896_abnormal_bone_mineralization | 0.68221049 |
163 | MP0005369_muscle_phenotype | 0.67573245 |
164 | MP0000026_abnormal_inner_ear | 0.67422570 |
165 | MP0003984_embryonic_growth_retardation | 0.66817862 |
166 | MP0003646_muscle_fatigue | 0.66551074 |
167 | MP0001340_abnormal_eyelid_morphology | 0.66384839 |
168 | MP0003935_abnormal_craniofacial_develop | 0.65939733 |
169 | MP0001485_abnormal_pinna_reflex | 0.65202312 |
170 | MP0000647_abnormal_sebaceous_gland | 0.65004439 |
171 | MP0002088_abnormal_embryonic_growth/wei | 0.63715769 |
172 | MP0003566_abnormal_cell_adhesion | 0.63428525 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Irregular epiphyses (HP:0010582) | 5.91685601 |
2 | Deep venous thrombosis (HP:0002625) | 5.30708201 |
3 | Epiphyseal dysplasia (HP:0002656) | 5.20611174 |
4 | Vitreoretinal degeneration (HP:0000655) | 5.10426873 |
5 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 4.74556249 |
6 | Hypobetalipoproteinemia (HP:0003563) | 4.55617791 |
7 | Abnormal tarsal ossification (HP:0008369) | 4.50927501 |
8 | Cupped ribs (HP:0000887) | 4.28325077 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 4.19598360 |
10 | Exercise-induced muscle cramps (HP:0003710) | 4.03824453 |
11 | Hypoplastic ischia (HP:0003175) | 3.97535729 |
12 | Abnormality of incisor morphology (HP:0011063) | 3.97485086 |
13 | Abnormality of the ischium (HP:0003174) | 3.91948608 |
14 | Flat capital femoral epiphysis (HP:0003370) | 3.75565527 |
15 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 3.71225727 |
16 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.64984571 |
17 | Facial shape deformation (HP:0011334) | 3.62989329 |
18 | Potter facies (HP:0002009) | 3.62989329 |
19 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 3.62178845 |
20 | Abnormal foot bone ossification (HP:0010675) | 3.45528447 |
21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42410736 |
22 | Increased serum pyruvate (HP:0003542) | 3.40934889 |
23 | Abnormality of glycolysis (HP:0004366) | 3.40614389 |
24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.40093269 |
25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.23099177 |
26 | Small epiphyses (HP:0010585) | 3.14782621 |
27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14532162 |
28 | Adrenal hypoplasia (HP:0000835) | 3.13750900 |
29 | Complement deficiency (HP:0004431) | 3.09928976 |
30 | Papillary thyroid carcinoma (HP:0002895) | 3.09140968 |
31 | Short femoral neck (HP:0100864) | 3.03829735 |
32 | Epidermoid cyst (HP:0200040) | 3.03519442 |
33 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.00483175 |
34 | Delayed epiphyseal ossification (HP:0002663) | 2.98815169 |
35 | Muscle fiber inclusion bodies (HP:0100299) | 2.97743578 |
36 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.95371742 |
37 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.94045820 |
38 | Exercise-induced myalgia (HP:0003738) | 2.93568153 |
39 | Genu varum (HP:0002970) | 2.92226121 |
40 | Hypolipoproteinemia (HP:0010981) | 2.90976416 |
41 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.88406230 |
42 | Abnormality of femoral epiphyses (HP:0006499) | 2.88406230 |
43 | Abnormality of the 2nd finger (HP:0004100) | 2.86091432 |
44 | Nemaline bodies (HP:0003798) | 2.83601318 |
45 | Abnormality of the frontal sinuses (HP:0002687) | 2.82398309 |
46 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.81859097 |
47 | Metaphyseal dysplasia (HP:0100255) | 2.81700560 |
48 | Arthropathy (HP:0003040) | 2.78761617 |
49 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.78064068 |
50 | Stillbirth (HP:0003826) | 2.76855646 |
51 | Myoglobinuria (HP:0002913) | 2.76277468 |
52 | Aplasia involving bones of the extremities (HP:0009825) | 2.75340624 |
53 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.75340624 |
54 | Aplasia of the phalanges of the hand (HP:0009802) | 2.75340624 |
55 | Stomach cancer (HP:0012126) | 2.74843589 |
56 | Mitral stenosis (HP:0001718) | 2.74788843 |
57 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.74103070 |
58 | Hypercholesterolemia (HP:0003124) | 2.73289224 |
59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72593505 |
60 | Flat acetabular roof (HP:0003180) | 2.71778507 |
61 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.70143784 |
62 | Abnormality of the femoral head (HP:0003368) | 2.68952336 |
63 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.62132284 |
64 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.59292348 |
65 | Absent epiphyses (HP:0010577) | 2.59292348 |
66 | Metaphyseal irregularity (HP:0003025) | 2.57804885 |
67 | Abnormality of the vertebral endplates (HP:0005106) | 2.55957578 |
68 | Irregular vertebral endplates (HP:0003301) | 2.46536574 |
69 | Redundant skin (HP:0001582) | 2.44639758 |
70 | Prostate neoplasm (HP:0100787) | 2.41975871 |
71 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.41220950 |
72 | Abnormality of the intrinsic pathway (HP:0010989) | 2.41145092 |
73 | Insidious onset (HP:0003587) | 2.41079669 |
74 | Termporal pattern (HP:0011008) | 2.41079669 |
75 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.40245005 |
76 | Hypoplastic scapulae (HP:0000882) | 2.40245005 |
77 | Mild short stature (HP:0003502) | 2.37365486 |
78 | Long clavicles (HP:0000890) | 2.37342806 |
79 | Periauricular skin pits (HP:0100277) | 2.34783730 |
80 | Preauricular pit (HP:0004467) | 2.34783730 |
81 | Joint hemorrhage (HP:0005261) | 2.33559985 |
82 | Pheochromocytoma (HP:0002666) | 2.33194410 |
83 | Overlapping toe (HP:0001845) | 2.30004895 |
84 | Asymmetry of the thorax (HP:0001555) | 2.28309523 |
85 | Abnormality of the nasal septum (HP:0000419) | 2.27011401 |
86 | Submucous cleft hard palate (HP:0000176) | 2.25933264 |
87 | Abnormality of complement system (HP:0005339) | 2.25092080 |
88 | Metaphyseal cupping (HP:0003021) | 2.24444730 |
89 | Fat malabsorption (HP:0002630) | 2.24017424 |
90 | Carpal synostosis (HP:0009702) | 2.22618142 |
91 | Abnormality of the Achilles tendon (HP:0005109) | 2.19371916 |
92 | Vascular calcification (HP:0004934) | 2.17740843 |
93 | Rimmed vacuoles (HP:0003805) | 2.17642055 |
94 | Cortical dysplasia (HP:0002539) | 2.16842370 |
95 | Thyroid carcinoma (HP:0002890) | 2.16768472 |
96 | Calcaneovalgus deformity (HP:0001848) | 2.16742852 |
97 | Hepatoblastoma (HP:0002884) | 2.16590582 |
98 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.15918877 |
99 | Intrahepatic cholestasis (HP:0001406) | 2.15023600 |
100 | Rhabdomyolysis (HP:0003201) | 2.14504993 |
101 | Unilateral renal agenesis (HP:0000122) | 2.14319225 |
102 | Hyperammonemia (HP:0001987) | 2.14176179 |
103 | Synostosis of carpal bones (HP:0005048) | 2.13637691 |
104 | Back pain (HP:0003418) | 2.13017995 |
105 | Neonatal short-limb short stature (HP:0008921) | 2.11299632 |
106 | Barrel-shaped chest (HP:0001552) | 2.10885955 |
107 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.08209406 |
108 | Blue irides (HP:0000635) | 2.06477470 |
109 | Shoulder girdle muscle weakness (HP:0003547) | 2.06213131 |
110 | Synostosis involving bones of the hand (HP:0004278) | 2.05069797 |
111 | Abnormality of carpal bone ossification (HP:0006257) | 2.04931847 |
112 | Xanthomatosis (HP:0000991) | 2.03947244 |
113 | Urinary urgency (HP:0000012) | 2.03596607 |
114 | Short hallux (HP:0010109) | 2.01785186 |
115 | Prolonged neonatal jaundice (HP:0006579) | 2.01046947 |
116 | Abnormality of the middle phalanges of the hand (HP:0009833) | 2.01014945 |
117 | Scanning speech (HP:0002168) | 2.00715967 |
118 | Enlarged epiphyses (HP:0010580) | 2.00081177 |
119 | Abnormality of the fibula (HP:0002991) | 1.99698276 |
120 | Fibular hypoplasia (HP:0003038) | 1.99658000 |
121 | Fibular aplasia (HP:0002990) | 1.99650416 |
122 | Fair hair (HP:0002286) | 1.98960842 |
123 | Limb-girdle muscle atrophy (HP:0003797) | 1.96766717 |
124 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96742907 |
125 | Broad alveolar ridges (HP:0000187) | 1.96370443 |
126 | Pulmonary artery stenosis (HP:0004415) | 1.94498843 |
127 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.93265934 |
128 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.93265934 |
129 | Abnormality of pain sensation (HP:0010832) | 1.93157834 |
130 | Impaired pain sensation (HP:0007328) | 1.93157834 |
131 | Osteoarthritis (HP:0002758) | 1.93136722 |
132 | Thoracolumbar scoliosis (HP:0002944) | 1.92921141 |
133 | Flattened epiphyses (HP:0003071) | 1.91829989 |
134 | Neoplasm of the adrenal cortex (HP:0100641) | 1.91212126 |
135 | Deformed tarsal bones (HP:0008119) | 1.89228793 |
136 | Neonatal hypoglycemia (HP:0001998) | 1.89199629 |
137 | Gout (HP:0001997) | 1.88891450 |
138 | Hypoplasia of the uterus (HP:0000013) | 1.88378256 |
139 | Lip pit (HP:0100267) | 1.86784189 |
140 | Neuroendocrine neoplasm (HP:0100634) | 1.86569051 |
141 | Micromelia (HP:0002983) | 1.85702013 |
142 | Vertebral arch anomaly (HP:0008438) | 1.84817340 |
143 | Spontaneous abortion (HP:0005268) | 1.84498070 |
144 | Microvesicular hepatic steatosis (HP:0001414) | 1.83729023 |
145 | Abnormal pancreas size (HP:0012094) | 1.82007431 |
146 | Abnormal vertebral ossification (HP:0100569) | 1.82003765 |
147 | Cardiovascular calcification (HP:0011915) | 1.81289607 |
148 | Exocrine pancreatic insufficiency (HP:0001738) | 1.80598874 |
149 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.79558429 |
150 | Hyperglycinemia (HP:0002154) | 1.78580755 |
151 | Retinal atrophy (HP:0001105) | 1.76473856 |
152 | Hypoalphalipoproteinemia (HP:0003233) | 1.76085719 |
153 | Pelvic girdle muscle weakness (HP:0003749) | 1.74468649 |
154 | Alveolar cell carcinoma (HP:0006519) | 1.74451807 |
155 | Short nail (HP:0001799) | 1.73624854 |
156 | Open mouth (HP:0000194) | 1.72457811 |
157 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.71078328 |
158 | Hammertoe (HP:0001765) | 1.70990428 |
159 | Short middle phalanx of finger (HP:0005819) | 1.70717366 |
160 | Cystic hygroma (HP:0000476) | 1.70457826 |
161 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.70200654 |
162 | Mixed hearing impairment (HP:0000410) | 1.70175600 |
163 | Bell-shaped thorax (HP:0001591) | 1.69286823 |
164 | Abnormality of the calcaneus (HP:0008364) | 1.69210953 |
165 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.69040343 |
166 | Myopathic facies (HP:0002058) | 1.68669047 |
167 | Acanthocytosis (HP:0001927) | 1.68596465 |
168 | Absent eyebrow (HP:0002223) | 1.68222946 |
169 | Abnormal cartilage morphology (HP:0002763) | 1.67768193 |
170 | Glomerulonephritis (HP:0000099) | 1.67743997 |
171 | Patent foramen ovale (HP:0001655) | 1.67581535 |
172 | Glossoptosis (HP:0000162) | 1.66350261 |
173 | Distal arthrogryposis (HP:0005684) | 1.65146492 |
174 | Proximal tubulopathy (HP:0000114) | 1.65089604 |
175 | Abnormality of glycine metabolism (HP:0010895) | 1.65048046 |
176 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.65048046 |
177 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.64138660 |
178 | Upper limb muscle weakness (HP:0003484) | 1.63352766 |
179 | Septate vagina (HP:0001153) | 1.60387682 |
180 | Hepatocellular carcinoma (HP:0001402) | 1.59941411 |
181 | Pterygium (HP:0001059) | 1.59291850 |
182 | Hyperglycinuria (HP:0003108) | 1.57291520 |
183 | Achilles tendon contracture (HP:0001771) | 1.54105301 |
184 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.54097653 |
185 | Steatorrhea (HP:0002570) | 1.53425347 |
186 | Abnormality of the gastric mucosa (HP:0004295) | 1.53418190 |
187 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.52401929 |
188 | Subaortic stenosis (HP:0001682) | 1.52401929 |
189 | Broad nasal tip (HP:0000455) | 1.51673468 |
190 | Ragged-red muscle fibers (HP:0003200) | 1.50878961 |
191 | Hyperalaninemia (HP:0003348) | 1.50244061 |
192 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.50244061 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERBB3 | 3.74120036 |
2 | STK38L | 3.05889599 |
3 | MAP3K3 | 2.93679313 |
4 | ZAK | 2.79191146 |
5 | BCR | 2.60609503 |
6 | BRD4 | 2.52067287 |
7 | MARK1 | 2.37479457 |
8 | NEK6 | 2.36719707 |
9 | BMPR2 | 2.29623113 |
10 | CASK | 2.25710546 |
11 | ICK | 2.24900946 |
12 | FRK | 2.23037932 |
13 | MST4 | 2.15711383 |
14 | TRIM28 | 2.15370563 |
15 | PRPF4B | 2.10420574 |
16 | MKNK2 | 2.09920838 |
17 | PBK | 2.08763101 |
18 | CDK12 | 2.02776030 |
19 | MAP2K7 | 2.02760484 |
20 | BMPR1B | 1.96316593 |
21 | WNK4 | 1.94571391 |
22 | NUAK1 | 1.94431880 |
23 | MAP3K14 | 1.91437232 |
24 | AKT3 | 1.86686771 |
25 | TRPM7 | 1.82767816 |
26 | OBSCN | 1.82463645 |
27 | MKNK1 | 1.76036945 |
28 | DYRK1B | 1.74350330 |
29 | MAP3K4 | 1.73779247 |
30 | NEK1 | 1.68051349 |
31 | STK39 | 1.61597179 |
32 | PLK2 | 1.59673333 |
33 | CDK6 | 1.54060751 |
34 | FGFR4 | 1.52579567 |
35 | MAPKAPK5 | 1.47324840 |
36 | PLK3 | 1.47216293 |
37 | LIMK1 | 1.45886469 |
38 | SGK2 | 1.40869902 |
39 | PHKG2 | 1.40863020 |
40 | PHKG1 | 1.40863020 |
41 | STK24 | 1.40084383 |
42 | SGK223 | 1.38781602 |
43 | SGK494 | 1.38781602 |
44 | EPHA2 | 1.38678621 |
45 | SIK3 | 1.28529028 |
46 | VRK1 | 1.27394681 |
47 | DYRK2 | 1.26965082 |
48 | EEF2K | 1.26344309 |
49 | OXSR1 | 1.24787920 |
50 | ADRBK2 | 1.24520638 |
51 | ERBB4 | 1.23788261 |
52 | PLK4 | 1.20775508 |
53 | SRPK1 | 1.17130097 |
54 | EPHA3 | 1.16832746 |
55 | TSSK6 | 1.16450794 |
56 | SCYL2 | 1.14198614 |
57 | CSNK1A1L | 1.13369611 |
58 | PDK2 | 1.12273607 |
59 | WEE1 | 1.10554402 |
60 | RPS6KA4 | 1.06874269 |
61 | DDR2 | 1.06377124 |
62 | NME1 | 1.04572480 |
63 | PINK1 | 1.03214384 |
64 | MAP2K4 | 1.02753580 |
65 | BRSK2 | 1.01270599 |
66 | YES1 | 1.00435081 |
67 | NEK9 | 0.98442649 |
68 | PDGFRA | 0.96347835 |
69 | PRKCE | 0.94462364 |
70 | CCNB1 | 0.94067290 |
71 | FGFR3 | 0.90576647 |
72 | STK3 | 0.90224312 |
73 | PRKD3 | 0.88001370 |
74 | MAP3K5 | 0.86445857 |
75 | CDK3 | 0.85754101 |
76 | RIPK1 | 0.85553106 |
77 | LATS1 | 0.85062462 |
78 | TXK | 0.83723333 |
79 | CHUK | 0.83211757 |
80 | EIF2AK3 | 0.82998303 |
81 | EIF2AK2 | 0.82304725 |
82 | IRAK3 | 0.81072647 |
83 | PRKG2 | 0.80770709 |
84 | BUB1 | 0.80046790 |
85 | PIK3CA | 0.79109654 |
86 | IRAK4 | 0.78559737 |
87 | MAP3K6 | 0.78527555 |
88 | DYRK3 | 0.78396133 |
89 | MAPK15 | 0.76949950 |
90 | PRKAA1 | 0.76924537 |
91 | MUSK | 0.76547055 |
92 | FGFR2 | 0.74209199 |
93 | SIK2 | 0.73929134 |
94 | AKT2 | 0.72885458 |
95 | FGFR1 | 0.72858188 |
96 | TTN | 0.71694971 |
97 | MET | 0.70817438 |
98 | EPHB1 | 0.69819392 |
99 | CSNK1G3 | 0.69778367 |
100 | MAPK13 | 0.68162680 |
101 | TAOK2 | 0.67563509 |
102 | TESK1 | 0.67225946 |
103 | PKN1 | 0.66200862 |
104 | CDK14 | 0.64262192 |
105 | EPHB2 | 0.64200949 |
106 | STK16 | 0.63832478 |
107 | DYRK1A | 0.63380182 |
108 | LMTK2 | 0.63329445 |
109 | FER | 0.62963394 |
110 | CSNK1G1 | 0.62295179 |
111 | IKBKB | 0.61354489 |
112 | SGK3 | 0.59213488 |
113 | RPS6KB1 | 0.58858812 |
114 | MAP3K2 | 0.57163695 |
115 | BRSK1 | 0.55093951 |
116 | RPS6KB2 | 0.54210934 |
117 | NLK | 0.54197006 |
118 | CSNK1E | 0.52129824 |
119 | MAPK11 | 0.50816922 |
120 | UHMK1 | 0.50707244 |
121 | CLK1 | 0.49585536 |
122 | SIK1 | 0.49012258 |
123 | CDK8 | 0.48503120 |
124 | CDK7 | 0.48420579 |
125 | TEC | 0.47334876 |
126 | MTOR | 0.46388974 |
127 | IKBKE | 0.46242511 |
128 | CAMK2D | 0.45179206 |
129 | RPS6KA5 | 0.45076859 |
130 | EIF2AK1 | 0.44623667 |
131 | PIM2 | 0.44437842 |
132 | GSK3A | 0.44322993 |
133 | CSNK1A1 | 0.43370628 |
134 | LATS2 | 0.43320447 |
135 | CDK18 | 0.42259480 |
136 | MAPK10 | 0.42090356 |
137 | PRKAA2 | 0.41826498 |
138 | MAP2K1 | 0.41000495 |
139 | MAPKAPK3 | 0.40830099 |
140 | CAMKK2 | 0.40391353 |
141 | INSRR | 0.40082428 |
142 | MAPK7 | 0.39961783 |
143 | CAMK2B | 0.38817137 |
144 | PAK3 | 0.38752441 |
145 | CDK9 | 0.38168504 |
146 | KSR1 | 0.37895031 |
147 | NTRK1 | 0.37627739 |
148 | IRAK1 | 0.37493661 |
149 | PIM1 | 0.35624830 |
150 | CSNK1G2 | 0.34437554 |
151 | MST1R | 0.34025445 |
152 | CDK15 | 0.33296710 |
153 | CSNK1D | 0.31392659 |
154 | RPS6KA1 | 0.30867073 |
155 | CDK11A | 0.28427777 |
156 | PRKACB | 0.28121664 |
157 | MAPK9 | 0.28108042 |
158 | RET | 0.26909778 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 4.77598074 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.29731188 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.07201717 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.06313646 |
5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.13331203 |
6 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.06407981 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88100173 |
8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.84993129 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71579892 |
10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.71083067 |
11 | Protein export_Homo sapiens_hsa03060 | 2.68140921 |
12 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.63596167 |
13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.59882980 |
14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.40965519 |
15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.39015438 |
16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.37356287 |
17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.21752669 |
18 | Retinol metabolism_Homo sapiens_hsa00830 | 2.15238585 |
19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.11171200 |
20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.86435324 |
21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.76437743 |
22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74364315 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.73190393 |
24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.67760386 |
25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.65945161 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62952509 |
27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.58240682 |
28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.55550974 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50002351 |
30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.45883643 |
31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42952205 |
32 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.33304487 |
33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31405654 |
34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28489993 |
35 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.27632048 |
36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27340367 |
37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27057650 |
38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26801065 |
39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26372990 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.24870165 |
41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22780825 |
42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22498364 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21589255 |
44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19589614 |
45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18260982 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17463583 |
47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15277523 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14008185 |
49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.12852698 |
50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09981644 |
51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09479956 |
52 | Phagosome_Homo sapiens_hsa04145 | 1.06409626 |
53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03473939 |
54 | RNA polymerase_Homo sapiens_hsa03020 | 1.02470680 |
55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01900066 |
56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01373334 |
57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00836318 |
58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00386689 |
59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98049425 |
60 | RNA degradation_Homo sapiens_hsa03018 | 0.96699339 |
61 | Peroxisome_Homo sapiens_hsa04146 | 0.95460287 |
62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93366394 |
63 | Mineral absorption_Homo sapiens_hsa04978 | 0.89781250 |
64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89676529 |
65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87789655 |
66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85849959 |
67 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84788889 |
68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.83951696 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.83748232 |
70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82751202 |
71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82511976 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81683543 |
73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78834644 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77268012 |
75 | Tight junction_Homo sapiens_hsa04530 | 0.76978885 |
76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76882338 |
77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76798532 |
78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76161409 |
79 | Lysine degradation_Homo sapiens_hsa00310 | 0.75920342 |
80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75775347 |
81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74756089 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72528555 |
83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72450686 |
84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71884921 |
85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71093628 |
86 | Malaria_Homo sapiens_hsa05144 | 0.70487625 |
87 | Melanoma_Homo sapiens_hsa05218 | 0.69556936 |
88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68769994 |
89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67927790 |
90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67921743 |
91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66893461 |
92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65159668 |
93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63649103 |
94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62614048 |
95 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62513651 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62102774 |
97 | Legionellosis_Homo sapiens_hsa05134 | 0.61003759 |
98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58199834 |
99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57571731 |
100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56633440 |
101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56062904 |
102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55875208 |
103 | Prostate cancer_Homo sapiens_hsa05215 | 0.55606805 |
104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55377160 |
105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51631981 |
106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50983211 |
107 | Cell cycle_Homo sapiens_hsa04110 | 0.49588493 |
108 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49351305 |
109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47904624 |
110 | Proteasome_Homo sapiens_hsa03050 | 0.47763720 |
111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47600018 |
112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47101897 |
113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45866482 |
114 | Adherens junction_Homo sapiens_hsa04520 | 0.45316453 |
115 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45194313 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.44733418 |
117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44346247 |
118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44091395 |
119 | Bladder cancer_Homo sapiens_hsa05219 | 0.43156704 |
120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41892644 |
121 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41673513 |
122 | ABC transporters_Homo sapiens_hsa02010 | 0.40513863 |
123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40509239 |
124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40273790 |
125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38815091 |
126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37196830 |
127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36939441 |
128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36854939 |
129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36103526 |
130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35493522 |
131 | Hepatitis C_Homo sapiens_hsa05160 | 0.34989857 |
132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34789271 |
133 | Influenza A_Homo sapiens_hsa05164 | 0.34748968 |
134 | RNA transport_Homo sapiens_hsa03013 | 0.34405901 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34274608 |
136 | Purine metabolism_Homo sapiens_hsa00230 | 0.34224119 |
137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33274825 |
138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32982283 |
139 | Spliceosome_Homo sapiens_hsa03040 | 0.30105248 |
140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30101272 |
141 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27890343 |
142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.26941411 |
143 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24366513 |
144 | Axon guidance_Homo sapiens_hsa04360 | 0.23900682 |
145 | Focal adhesion_Homo sapiens_hsa04510 | 0.23429134 |
146 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22511357 |
147 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.22157063 |
148 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.21743555 |
149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21195676 |
150 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.21125730 |
151 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.20184649 |
152 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19119511 |